Packaged Medicaments in   United States

Overview In January 2024 United States' Packaged Medicaments exports accounted up to $2.55B and imports accounted up to $7.89B, resulting in a negative trade balance of $5.34B. Between January 2023 and January 2024 the exports of United States'   Packaged Medicaments have decreased by $-353M (-12.2%) from $2.9B to $2.55B, while imports decreased by $-727M (-8.45%) from $8.61B to $7.89B.

Destinations In January 2024, Packaged Medicaments were exported mostly to United Kingdom ($582M), Japan ($319M), Canada ($239M), Netherlands ($172M), and Belgium ($159M), and were imported mostly from India ($1.52B), Ireland ($1.08B), Switzerland ($741M), China ($556M), and Slovenia ($437M).

Growth In January 2024, the decrease in Packaged Medicaments's year-by-year exports was explained primarily by a decrease in exports to Netherlands ($-168M or -47.2%), Germany ($-47.9M or -46.7%), and Canada ($-24.2M or -9.39%). In January 2024, the decrease in Packaged Medicaments's year-by-year imports was explained primarily by a decrease in imports from Germany ($-119M or -16.8%), Belgium ($-36.5M or -25.5%), and Sweden ($-33.6M or -53.5%).